Latest Influenza research Stories
DALLAS, January 21, 2015 /PRNewswire/ -- ReportsnReports.com adds Global and Chinese Pandemic Influenza Vaccine Industry, 2009-2019 Market Research Report and Research
Farm Show Runs from Jan. 10-17 HARRISBURG, Pa., Jan.
Market Research Reports.biz now carries a research report titled, “Influenza Vaccines Market & Forecast - Worldwide Analysis” that delivers a comprehensive analysis of the global influenza
Flublok is the world's first FDA approved recombinant protein vaccine for the prevention of seasonal influenza LONDON, Dec.
- The first and only four-strain influenza vaccine option administered intradermally - SWIFTWATER, Pa., Dec.
Dalton awarded funding from ISTPCanada as part of an international vaccine development project under the 2013 Canada-China Joint Initiative on Human Vaccine Research and Development program
Experimental Ebola vaccine developed by Public Health Agency of Canada OTTAWA, Nov.
ROCKVILLE, Md., Nov.
- Includes New Data Showing Fluzone High-Dose Vaccine More Efficacious Than Standard-Dose Fluzone Vaccine - SWIFTWATER, Pa., Nov.
- totally perplexed and mixed up.